GI & HPB Oncology Hospital in Mumbai
Gleneagles Hospital, Mumbai is at the forefront of comprehensive cancer care, specialising in advanced GI and HPB oncology. These cancers of the liver, pancreas, and gallbladder represent some of the most complex challenges in medicine, requiring visionary surgical planning and a seamlessly coordinated multidisciplinary team. We are dedicated to pushing the boundaries of what is possible in the treatment of digestive cancers.
At Gleneagles Hospitals, we leverage future-ready technology and data-driven science to safeguard your health and recovery. Our focus is on minimally invasive surgery and constant monitoring to ensure you stay well. We combine our clinical expertise with a commitment to your dignity, providing a reliable and supportive treatment journey for anyone facing complex digestive cancers.
What is GI & HPB Oncology
GI & HPB oncology is a specialised field dedicated to the diagnosis and treatment of cancers affecting the gastrointestinal tract and hepatopancreatobiliary system. This includes cancers of the:
- Oesophagus and stomach
- Small and large intestines, including colorectal cancers
- Liver and bile ducts
- Gallbladder
- Pancreas
Management of these cancers requires accurate staging, tumour-specific therapy, and carefully timed surgical intervention. Treatment plans are personalised based on tumour biology, disease spread, and the patient’s overall health.
Why GI & HPB Oncology Care is Needed
You need specialised GI & HPB oncology when digestive cancers are suspected. Early expert involvement is the key to an accurate diagnosis and better treatment options. Doctors recommend structured management if:
- Abdominal pain, weight loss, or jaundice point toward cancer
- Scans or endoscopies reveal suspicious masses in the digestive organs
- Biopsy confirms you require surgery, chemotherapy, or radiation
- Cancer has spread and needs a high level of coordinated care
We also evaluate:
- Tumour stage and whether it involves blood vessels
- Your liver function and nutritional status
- The urgency to prevent bleeding or blockages
Timely GI & HPB oncology intervention significantly improves survival, controls symptoms, and manages the disease long-term.
Who is Suitable for GI & HPB Oncology Treatment
We evaluate treatment suitability for every patient individually. Decisions are based on the disease characteristics and your physical fitness. We move forward with treatment when:
- Cancer is confirmed or strongly suspected in the GI or HPB organs
- The disease stage allows for curative or life-prolonging therapy
- Heart, lung, liver, and kidney functions are strong enough
- Your nutritional and performance status are adequate
Age is not the deciding factor. Many older people manage treatment well when their health is stable. Our team of specialists reviews every case together to ensure your safety. Our focus is to provide you with the greatest benefit while protecting you from unnecessary risk.
When GI & HPB Oncology Treatment is Not Advised
In certain circumstances, immediate aggressive treatment may not be safe or beneficial. Doctors may delay or avoid major intervention when:
- Severe organ dysfunction prevents surgery or chemotherapy
- Advanced disease limits meaningful clinical benefit
- Active infections or medical instability increase complication risk
- Frailty or poor nutritional status reduces treatment tolerance
In such cases, stabilisation, supportive therapy, or palliative care may be recommended first. The emphasis remains on comfort, dignity, and quality of life, while reassessing whether treatment can become possible later.


